Product Information
NEBIVOLOL 20 MG TABLET is a generic product labeled by Lifestar Pharma LLC, priced at $0.1899 per EA under NDC 70756029390. Its NADAC has been published 86 times since Jul 12, 2023.
FDA first approved this application on Nov 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Nebivolol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756029390
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
NEBIVOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216172FDA Approved
11/14/2022
TE Code
AB
On Market Since
11/14/2022
Pharmacological Classes
Price Statistics
The NADAC for NEBIVOLOL 20 MG TABLET has been published 86 times since Jul 12, 2023, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1899 per EA |
|---|---|
| All-time high | $0.2611 (Jul 12, 2023) |
| All-time low | $0.1369 (Nov 20, 2024) |
| Median price | $0.1933 |
| Average price | $0.1984 |
| Largest weekly change | +29.6% (Aug 21, 2024) |
| Weeks tracked | 86 |
| Tracking since | Jul 12, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-21.0%
5Y
N/A
All
-27.3%
Last surveyed Feb 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nebivolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEBIVOLOL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEBIVOLOL 20 MG TABLET, manufactured by Lifestar Pharma LLC, is $0.1899 per EA (NDC 70756029390), effective Feb 26, 2025.
How has the price of NEBIVOLOL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEBIVOLOL 20 MG TABLET has declined 27.3%. It has been tracked across 86 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for NEBIVOLOL 20 MG TABLET?
Since Jul 12, 2023, the NADAC for NEBIVOLOL 20 MG TABLET has ranged from a low of $0.1369 (Nov 20, 2024) to a high of $0.2611 (Jul 12, 2023), with a median of $0.1933 per EA.
Are there cheaper alternatives to NEBIVOLOL 20 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEBIVOLOL 20 MG TABLET, is $0.1749 per EA — about 8% below NEBIVOLOL 20 MG TABLET.
Who manufactures NEBIVOLOL 20 MG TABLET?
NEBIVOLOL 20 MG TABLET (NDC 70756029390) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.